Clinical trial Recruiting at 1 site Interventional Ages 65 and up

Inspiring older adults: a home-friendly breathing muscle training program

Official title: The Application of Inspiratory Muscle Training in Health Promotion and Disability Prevention for Community-Dwelling Older Adults

Run by Hungkuang University · NCT07713589 · Data updated 2026-11-12

This study tests whether inspiratory muscle training helps healthy adults aged 65 and older improve breathing, daily activity, and quality of life.

More Community-dwelling Older Adults trials

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment80 (estimated)
SponsorHungkuang University
Academic / other
Locations1 site (Taichung, Taiwan)
StatusRecruiting
StartedSeptember 23, 2025
Main results expectedApril 30, 2026
Study endsAugust 30, 2026
Registry record updatedJuly 20, 2026
Trial IDNCT07713589 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Potential participants are adults aged 65 or older who are cognitively intact, able to go out independently, and willing to participate in a health-promotion program during the study period.

Probably not a fit

Individuals with serious illnesses, complex arrhythmias, cognitive impairment, or other conditions that interfere with training or MIP measurement may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study targets healthy community-dwelling adults aged 65 and above. It investigates the effects of inspiratory muscle training (IMT) using a Triflow device on respiratory strength, functional exercise capacity, and quality of life. Participants will engage in IMT as part of a health-promotion program, with outcomes focused on breathing efficiency, balance-related factors, and overall function. The trial is conducted at Hungkuang University in Taichung, Taiwan, and excludes individuals with serious illnesses or conditions that would interfere with training or measurements. The study builds on existing evidence that strengthening the diaphragm and related muscles can improve posture, reduce fatigue, and potentially lower fall risk in older adults.

Why it matters

Potential benefit: If successful, participants may experience better breathing efficiency, greater physical capacity, and improved quality of life.

How similar studies have gone: Previous studies in older adults suggest IMT can improve respiratory and functional outcomes, but application to community-dwelling, healthy seniors remains less established, making these results exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Aged ≥65 years.
2. Normal cognitive function
3. No psychiatric disorders or Alzheimer's disease.
4. Able to go out independently and perform self-care.
5. Willing and able to participate throughout the health-promotion program.

Exclusion Criteria:

1. Individuals whom a physician has determined have a serious illness for which exercise is not recommended.
2. Individuals with functional limitations that may interfere with inspiratory muscle training (IMT) and/or maximal inspiratory pressure (MIP) measurement-for example, unstable angina, complex arrhythmias, rheumatologic disease, active infectious disease, or cognitive impairment.

Where it's running

  • HUNGKUANG University
    Taichung, Taiwan, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.